The BCBS FEP program, which covers federal employees, generally offers the most comprehensive weight loss medication coverage within the BCBS system
Simple timing framework Baseline Discuss baseline labs before starting or escalating, especially with diabetes, kidney disease, gallbladder history, eating-disorder history, or major calorie restriction
In addition, since GLP-1 is also produced locally within pancreatic islets, and its expression increases with the progress of diabetes development 22,23,24,25,26,27 , linagliptin may exert insulinotropic and glucagonostatic effects directly on the islets by elevating local GLP-1 concentrations
This means that your concerns about dizziness or any other symptoms related to Mounjaro can be addressed with full context, improving the quality of recommendations and care plans
And after trials showed dramatic results, FDA approval for weight loss followed in 2021
PubMed CrossRef Hegeds C, Kovcs D, Kiss R, et al